Refine Search Results
Search Results Table
| Law | Result Summary | |
|---|---|---|
| Part I Title XV Chapter 94C Section 19B |
Dispensing, possessing and administrating opioid antagonist
who, acting in good faith, administers an opioid antagonist to an individual appearing to experience an opioid-related overdose shall not, as a result ... |
|
| Part III Title V Chapter 260 Section 2F |
Prescription opioids actions
cause of action concerning prescription opioids brought against Purdue Pharma L.P., Purdue ... This section shall apply regardless of when any such action or claim shall have accrued ... |
|
| Part I Title XV Chapter 94C Section 18C |
Patient education required before issuance of opioid prescription
Prior to issuing a prescription for an opioid contained in Schedule II of section 3, a ... with a the patient regarding the quantity of the opioid and a patient's option to fill the ... |
|
| Part I Title XXII Chapter 176G Section 4Y |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by an ... |
|
| Part I Title IV Chapter 32A Section 17L |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by the ... |
|
| Part I Title XXII Chapter 176B Section 4GG |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by an ... |
|
| Part I Title XXII Chapter 175 Section 47EE |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by such ... |
|
| Part I Title XXII Chapter 176A Section 8GG |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by the ... |
|
| Part I Title XV Chapter 94C Section 19B1/2 |
Exchange of naloxone or other opioid antagonist between registered entities
convey or exchange naloxone or another opioid antagonist approved by the department to or ... of unexpired naloxone or other approved opioid antagonist; provided, however, that such an ... |
|
| Part I Title XV Chapter 94C Section 6A |
Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners
than 300 patients receiving treatment for opioid dependency in the form of opioid agonist therapy provided by physicians who are ... |
|
| Part I Title XVI Chapter 112 Section 12FF |
Immunity of person administering naloxone or other opioid antagonist to person experiencing opiate-related overdose
by administering naloxone or any other opioid antagonist, as defined in section 19B of ... |
|
| Part I Title XVIII Chapter 127 Section 17B |
Medication-assisted treatment for opioid use disorder for state detainees or prisoners at certain facilities
shall offer medication-assisted treatment for opioid use disorder to a state detainee or ... use in medication-assisted treatment for opioid use disorder; provided however, that such ... |
|
| Part I Title XV Chapter 94C Section 19C |
High opiate overdose area pharmacies required to maintain continuous supply of naloxone rescue kits or opioid antagonist medications
supply of naloxone rescue kits or opioid antagonist medications, as defined in section 19B ... Pharmacists employed in locations covered by the regulations shall be subject to the ... |
|
| Part I Title XVIII Chapter 127 Section 17C |
Re-entry treatment plan for state detainee or prisoner requiring treatment for opioid use disorder
or prisoner requires treatment for opioid use disorder, the qualified addiction specialist ... and Drug Administration for use in medication-assisted treatment for opioid use disorder ... |
|
| Part I Title XVI Chapter 111 Section 25J 1/2 |
Intervention prior to discharge from acute-care hospital or satellite emergency facility to reduce risk of subsequent harm and fatality following opioid-related overdose
harm and fatality following an opioid-related overdose including, but not limited to ... who is administered or prescribed an opioid agonist treatment in an acute care hospital ... |
|
| Part I Title XVII Chapter 118E Section 10I |
Coverage for administration of all federal Food and Drug Administration approved drugs for opioid or alcohol dependence treatment
approved drugs for the treatment of opioid or alcohol dependence and shall establish ... For the purposes of this section, ''clinical stabilization services'' shall mean a 24&ndash ... |
|
| Part I Title XV Chapter 94C Section 32E |
Trafficking in marihuana, cocaine, heroin, synthetic opioids, morphine, opium, etc.; eligibility for parole
(a) Any person who trafficks in marihuana by knowingly or intentionally manufacturing, distributing, dispensing, or cultivating or possessing with intent to manufacture, distribute ... |
|
| Part I Title XV Chapter 94C Section 18A |
Prerequisites for issuing outpatient extended-release long-acting opioid in a non-abuse deterring form; written pain management treatment plan for long-term pain management
recommends that an extended-release long-acting opioid be utilized during the course of ... Such an agreement shall be filed in the patient's medical record or included in the ... |
|
| Part I Title XVI Chapter 111 Section 51 1/2 |
Substance use disorder evaluation and treatment for acute-care hospital or satellite emergency facility patient experiencing opioid-related overdose
by the treating clinician to be experiencing an opioid-related overdose, or who has been ... that the minor has suffered from an opioid-related overdose and that an evaluation ... |
|
| Part I Title II Chapter 10 Section 35OOO |
Summer Camp Stabilization Trust Fund
than 1 person qualified by experience with opioid use disorder, either first-hand or as a family member of an individual with opioid use disorder; and 10 people to be appointed ... |
|
| Part I Title XVIII Chapter 127 Section 17D |
Reporting of costs and outcomes of medication-assisted treatment programs and re-entry treatment plans under Secs. 17B and 17C
who received medication-assisted treatment for opioid use disorder during the 90 days ... did not receive medication-assisted treatment for opioid use disorder and those who did ... |
|
| Part I Title II Chapter 17 Section 13 |
Drug formulary commission
abuse or (ii) resists extraction of the opioid by common solvents such as water, alcohol ... a prodrug technique that limits opioid activity until transformed in the gastrointestinal ... |
|
| Part I Title IV Chapter 32A Section 17Q |
Pain management access plan
that serve as alternatives to opioid prescribing, in accordance with guidelines developed ... preferential coverage to prescribing opioids without other pain management modalities ... |
|
| Part I Title XXII Chapter 176G Section 4EE |
Pain management access plans
that serve as alternatives to opioid prescribing, in accordance with guidelines developed ... preferential coverage to prescribing opioids without other pain management modalities ... |
|
| Part I Title XXII Chapter 175 Section 47KK |
Pain management access plans
that serve as alternatives to opioid prescribing, in accordance with guidelines developed ... preferential coverage to prescribing opioids without other pain management modalities ... |
|